Skip to content

Sustainable UHPLC-MS/MS assay for ultra-sensitive simultaneous quantification of amoxicillin and flucloxacillin with application to a bioequivalence study.

Aug 2026 · Analytical and Bioanalytical Chemistry · 0 citations · 43 references
Medicine

TL;DR

The developed UHPLC-MS/MS method was successfully applied in a bioequivalence study involving 33 healthy volunteers following oral administration of a single 5 mL dose of Flucamox® 250 mg, enabling comprehensive pharmacokinetic evaluation while promoting sustainable and resource-efficient analytical practices.

View source

Similar papers

Open access Sep 2026

A sensitive and high-throughput LC-MS/MS method for the determination of ibuprofen: Application to a gender-comparative pharmacokinetic study

Ibuprofen is a nonsteroidal anti-inflammatory drug first launched in England in 1969, yet its pharmacokinetic profile in healthy Chinese volunteers remains insufficiently characterized. In this study, a sensitive and reliable ultra-high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method wa...

Mei-Ah Yang, Kui He, Yu-Jie Mo et al. · 0 citations
Sep 2026

SIL-IS LC-MS/MS method for rapid quantification of phloroglucinol in human plasma: development, validation and application to a pharmacokinetic study.

Phloroglucinol is a smooth muscle relaxant widely used for the symptomatic treatment of gastrointestinal, biliary, and genitourinary spasms. A sensitive, rapid, and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method incorporating a stable isotope-labeled internal standard (SIL-IS, phloroglucinol-13...

Qi-Qin Sun, Xiang-Hong Li, Yun-Jie Dong et al. · 0 citations
Open access Aug 2026

A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma.

A sensitive and validated liquid chromatography-tandem mass spectrometry method was developed for the simultaneous quantification of the anti-COVID-19 agents molnupiravir, its active metabolite N-hydroxycytidine (NHC), and baricitinib in human plasma, and met the acceptance criteria.

Fatma H. Ghazy, Ramzia I. El-Bagary, Samar H. Fahim et al. · 0 citations
Open access Sep 2026

BIOANALYTICAL LC-MS METHOD FOR DETECTION AND QUANTIFICATION OF NIFURTIMOX IN HUMAN PLASMA

Objective: Nifurtimox is a type of nitrofuran derivative employed for treating sleeping sickness as well as Chagas disease. The aim is to develop and validate a precise and specific liquid chromatography mass spectrometric technique for the estimation of Nifurtimox in human plasma.Material and Method: Chromatographic s...

J. K. Bokam, Jagadeesh Adari, Ch Rama Naidu Gorripati et al. · 0 citations
Open access Sep 2026

An Lc-Ms/Ms Method Development and Validation for the Quantification of Lurbinectedin in Biological Matrices; Application to Kinetic Study in Rabbits

Objective: The primary objective of the present research was to develop an accurate liquid chromatography and tandem mass spectrometry (LC-MS/MS) technique utilizing electrospray ionization for the quantification of Lurbinectedin in biological matrices. Methods: The components were isolated using chromatographic techni...

P. Sankar, Naresh Panigrahi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.